Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 656 participants.
Also called NCT01220622
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 656 participants
- Registry
-
NCT01220622
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01220622. Randomized; quadruple masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2012-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
- Acronym
- NICE
- Condition
- Stroke
- Condition
- Mild Cognitive Impairment
- Intervention (Drug)
- Nimodipine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Ministry of Science and Technology of the People´s Republic of China
Record details
- Record id
cardio:ct-nct01220622- Content hash
b805d600a3824005cb2d087b9d8eadea958ee9e124e8153bf7d5bd96029f285a